Literature DB >> 18667395

Epidemiology of biliary tract cancers: an update.

G Randi1, M Malvezzi, F Levi, J Ferlay, E Negri, S Franceschi, C La Vecchia.   

Abstract

BACKGROUND: Biliary tract cancer (BTC) is a rare cancer in Europe and North America, characterized by wide geographic variation, with high incidence in some areas of Latin America and Asia.
MATERIALS AND METHODS: BTC mortality and incidence have been updated according to recent data, using joinpoint regression analysis.
RESULTS: Since the 1980s, decreasing trends in BTC mortality rates (age-standardized, world standard population) were observed in the European Union as a whole, in Australia, Canada, Hong Kong, Israel, New Zealand, and the United States, and high-risk countries such as Japan and Venezuela. Joinpoint regression analysis indicates that decreasing trends were more favorable over recent calendar periods. High-mortality rates are, however, still evident in central and eastern Europe (4-5/100,000 women), Japan (4/100,000 women), and Chile (16.6/100,000 women). Incidence rates identified other high-risk areas in India (8.5/100,000 women), Korea (5.6/100,000 women), and Shanghai, China (5.2/100,000 women).
CONCLUSIONS: The decreasing BTC mortality trends essentially reflect more widespread and earlier adoption of cholecystectomy in several countries, since gallstones are the major risk factor for BTC. There are, however, high-risk areas, mainly from South America and India, where access to gall-bladder surgery remains inadequate.

Entities:  

Mesh:

Year:  2008        PMID: 18667395     DOI: 10.1093/annonc/mdn533

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  96 in total

1.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

3.  A Report of Two Cases of Leptomeningeal Carcinomatosis Arising from Gallbladder Carcinoma.

Authors:  Dinesh Chandra Doval; Saud Azam; Rupal Sinha; Ullas Batra; Anurag Mehta; Avinash Rao
Journal:  J Gastrointest Cancer       Date:  2015-12

Review 4.  Progression of targeted therapy in advanced cholangiocarcinoma.

Authors:  Yingying Huang; Xiaomei Li; Yunbo Zhao
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

5.  A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy.

Authors:  Dinesh Chandra Doval; Saud Azam; Anurag Mehta; Ankur Pruthi; Ullas Batra; Kumardeep Dutta Choudhury; Kapil Kumar
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 6.  Immunotherapeutic Approaches to Biliary Cancer.

Authors:  Urvi A Shah; Amara G Nandikolla; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2017-07

7.  Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Authors:  Jill Koshiol; Yu-Tang Gao; Amanda Corbel; Troy J Kemp; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Asif Rashid; Bingsheng Wang; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

8.  Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review.

Authors:  Zheng-Yun Zou; Jing Yan; Yu-Zheng Zhuge; Jun Chen; Xiao-Ping Qian; Bao-Rui Liu
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

9.  Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.

Authors:  Preeti Sharma; Shushruta Bhunia; Satish S Poojary; Dinesh S Tekcham; Mustafa Ahmed Barbhuiya; Sanjiv Gupta; Braj Raj Shrivastav; Pramod Kumar Tiwari
Journal:  Tumour Biol       Date:  2016-09-14

10.  Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.

Authors:  A D Wagner; P Buechner-Steudel; M Moehler; H Schmalenberg; R Behrens; J Fahlke; A Wein; S Behl; O Kuss; G Kleber; W E Fleig
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.